BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28385143)

  • 1. Australian childhood immunisation coverage, 1 July 2015 and 30 June 2016 cohort, assessed as at 30 September 2016.
    Hendry AJ
    Commun Dis Intell Q Rep; 2017 Mar; 41(1):E106-E108. PubMed ID: 28385143
    [No Abstract]   [Full Text] [Related]  

  • 2. Australian childhood immunisation coverage, April to June cohort, assessed as at 30 September 2014.
    Hull BP
    Commun Dis Intell Q Rep; 2015 Mar; 39(1):E167-8. PubMed ID: 26063091
    [No Abstract]   [Full Text] [Related]  

  • 3. Australian childhood immunisation coverage, 1 January to 31 March cohort, assessed as at 30 June 2014.
    Hull BP
    Commun Dis Intell Q Rep; 2015 Mar; 39(1):E165-6. PubMed ID: 26063090
    [No Abstract]   [Full Text] [Related]  

  • 4. Australian childhood immunisation coverage, 1 July to 30 June cohort, assessed as at 30 September 2015.
    Hendry A;
    Commun Dis Intell Q Rep; 2016 Mar; 40(1):E177-8. PubMed ID: 27080025
    [No Abstract]   [Full Text] [Related]  

  • 5. Australian childhood immunisation coverage, 1 April 2014 to 31 March 2015, assessed as at 30 June 2015.
    Hull BP;
    Commun Dis Intell Q Rep; 2015 Dec; 39(4):E626-7. PubMed ID: 26779727
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S
    BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From the Centers for Disease Control and Prevention. Reported vaccine-preventable diseases--United States, 1993, and the childhood immunization initiative.
    JAMA; 1994 Mar; 271(9):651-2. PubMed ID: 8309018
    [No Abstract]   [Full Text] [Related]  

  • 9. [Toward a New Immunization Schedule in Spain, 2016 (Part 2)].
    Navarro-Alonso JA; Taboada-Rodríguez JA; Limia-Sánchez A;
    Rev Esp Salud Publica; 2016 Mar; 90():E3. PubMed ID: 26960345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood immunization procedures.
    Krugman S; Katz SL
    JAMA; 1977 May; 237(20):2228-30. PubMed ID: 576912
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.
    Marshall H; McIntyre P; Roberton D; Dinan L; Hardt K
    Int J Infect Dis; 2010 Jan; 14(1):e41-9. PubMed ID: 19467896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reported vaccine-preventable diseases--United States, 1993, and the childhood immunization initiative.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Feb; 43(4):57-60. PubMed ID: 8295625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine.
    Black S; Greenberg DP
    Expert Rev Vaccines; 2005 Dec; 4(6):793-805. PubMed ID: 16372875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric disease burden and vaccination recommendations: understanding local differences.
    Gentile A; Bhutta Z; Bravo L; Samy AG; Garcia RD; Hoosen A; Islam T; Karimi A; Salem M; Simasathien S; Sohail A; Watanaveeradej V; Wiedenmayer K; Schmitt HJ
    Int J Infect Dis; 2010 Aug; 14(8):e649-58. PubMed ID: 20181506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Have your young pediatric patients been immunized properly?
    Waldman HB
    ASDC J Dent Child; 1998; 65(2):107-10. PubMed ID: 9617450
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b.
    de Melker HE; van den Hof S; Berbers GA; Conyn-van Spaendonck MA
    Vaccine; 2003 Jan; 21(7-8):716-20. PubMed ID: 12531347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The performance of the expanded programme on immunization in a rural area of Mozambique.
    Lanaspa M; Balcells R; Sacoor C; Nhama A; Aponte JJ; Bassat Q
    Acta Trop; 2015 Sep; 149():262-6. PubMed ID: 26095045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statement on the recommended use of pentavalent and hexavalent vaccines. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Feb; 33(ACS-1):1-14. PubMed ID: 17294559
    [No Abstract]   [Full Text] [Related]  

  • 20. Routine active immunisations in paediatric practice.
    Jain AM
    J Indian Med Assoc; 1968 Nov; 51(9):452-6. PubMed ID: 5729064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.